Home > Journals > Minerva Medica > Past Issues > Minerva Medica 2023 December;114(6) > Minerva Medica 2023 December;114(6):815-24

CURRENT ISSUE
 

JOURNAL TOOLS

Publishing options
eTOC
To subscribe
Submit an article
Recommend to your librarian
 

ARTICLE TOOLS

Publication history
Reprints
Permissions
Cite this article as
Share

 

ORIGINAL ARTICLE   

Minerva Medica 2023 December;114(6):815-24

DOI: 10.23736/S0026-4806.22.08018-1

Copyright © 2022 EDIZIONI MINERVA MEDICA

language: English

Coronary artery calcium score is a prognostic factor for mortality in idiopathic pulmonary fibrosis

Antonella CAMINATI 1 , Maurizio ZOMPATORI 2, 3, Nicoletta FUCCILLO 1, Andrea SONAGLIONI 4, Davide ELIA 1, Roberto CASSANDRO 1, Roberta TREVISAN 2, Anna RISPOLI 2, Giuseppe PELOSI 5, Sergio HARARI 1, 6

1 Unit of Pneumology and Semi-Intensive Respiratory Therapy, Section of Respiratory Pathophysiology and Pulmonary Hemodynamics, IRCCS MultiMedica, Milan, Italy; 2 Department of Diagnostic Imaging, IRCCS MultiMedica, Milan, Italy; 3 DIMES Department, University of Bologna, Bologna, Italy; 4 Unit of Cardiology, IRCCS MultiMedica, Milan, Italy; 5 Intercompany Service of Pathological Anatomy, Scientific and Technological Pole, IRCCS MultiMedica, Milan, Italy; 6 Department of Clinical Sciences and Community Health, University of Milan, Milan, Italy



BACKGROUND: Cardiovascular diseases are frequent in idiopathic pulmonary fibrosis (IPF) and impact on survival. We investigated the association of coronary artery calcium (CAC) score at IPF diagnosis and during mid-term follow-up, with adverse cardiovascular events and all-cause mortality.
METHODS: Consecutive patients with IPF were retrospectively analyzed. Demographic data, smoking history, comorbidities and pulmonary function tests (PFTs) were recorded. All patients had at least two chest high resolution computed tomography (HRCT) performed 2 years apart. The total CAC score and visual fibrotic score were calculated, and all clinically significant cardiovascular events and deaths were reported.
RESULTS: The population consisted of 79 patients (57 males, mean age: 74.4±7.6 years); 67% of patients had a history of smoking, 48% of hypertension, 37% of dyslipidemia and 22.8% of diabetes. The visual score was 21.28±7.99% at T0 and 26.54±9.34% at T1, respectively (T1-T0 5.26±6.13%, P<0.001). CAC score at T0 and at T1 was 537.93±839.94 and 759.98±1027.6, respectively (T1-T0 224.66±406.87, P<0.001). Mean follow-up time was 2.47±1.1 years. On multivariate analysis, male sex (HR=3.58, 95% CI: 1.14-11.2) and CAC score at T0 (HR=1.04, 95% CI: 1.01-1.07) correlated with mortality and cardiovascular events. CAC score at T0≥405 showed 82% sensitivity and 100% specificity for predicting mortality and adverse cardiovascular events.
CONCLUSIONS: IPF patients with a CAC score at diagnosis ≥405 have a poor prognosis over a mid-term follow-up. A higher CAC score is associated with mortality and cardiovascular events.


KEY WORDS: Calcinosis; Coronary artery disease; Atherosclerosis; Lung diseases, interstitial

top of page